Search company, investor...
SkinMed company logo

SkinMed

skinmed.co.uk

Stage

Other Investors | Alive

About SkinMed

SkinMed was created to assist in the research, development, sale, and distribution of dermatological products, designed to be beneficial to skin health.

Headquarters Location

England,

United Kingdom

+44 0333 247 2474

Missing: SkinMed's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SkinMed's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SkinMed Patents

SkinMed has filed 1 patent.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Nicotinic antagonists
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/14/2018

10/18/2022

Biomaterials, Dosage forms, Drug delivery devices, Nanotechnology, Proteins

Grant

Application Date

6/14/2018

Grant Date

10/18/2022

Title

Related Topics

Biomaterials, Dosage forms, Drug delivery devices, Nanotechnology, Proteins

Status

Grant

SkinMed Frequently Asked Questions (FAQ)

  • What is SkinMed's latest funding round?

    SkinMed's latest funding round is Other Investors.

  • Who are the investors of SkinMed?

    Investors of SkinMed include Braveheart Investment Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.